Skip to main content
. 2013 Oct 25;3(10):e003446. doi: 10.1136/bmjopen-2013-003446

Table 1.

Baseline characteristics of the 1255 participants by quartile of average walking speed

Variable All Participants (n=1255) I Quartile (n=316) II Quartile (n=313) III Quartile (n=300) IV Quartile (=326) p for trend
AWS
 (km/h) 4.3 (0.8) 3.4 (0.3) 4.1 (0.1) 4.6 (0.2) 5.5 (0.5) <0.001
  (m/s) 1.19 (0.22) 0.94 (0.08) 1.13 (0.02) 1.27 (0.05) 1.53 (0.14)
Deaths (n) 141 68 43 18 12 <0.001
Age (year) 61 (10) 65 (9) 63 (9) 59 (9) 57 (9) <0.001
Risk factor
 BMI 27.6 (3.4) 28.3 (3.7) 27.6 (3.3) 27.7 (3.2) 27.0 (3.3) <0.001
 LV ejection fraction (%) 56 (10) 53 (11) 56 (9) 57 (11) 58 (10) 0.002
 Family history (%) 53.7 48.4 51.7 54.3 60.7 0.001
 Fasting glucose (mg/dL) 107 (27) 110 (28) 110 (28) 106 (29) 105 (28) 0.03
 Total cholesterol (mg/dL) 194 (42) 195 (47) 199 (43) 194 (41) 188 (39) 0.04
 HDL cholesterol (mg/dL) 49 (14) 50 (16) 49 (13) 47 (14) 50 (13) 0.55
 Serum triglycerides (mg/dL) 139 (80) 147 (97) 138 (71) 143 (80) 129 (67) 0.046
 Serum creatinine (mg/dL) 1.1 (0.2) 1.2 (0.3) 1.1 (0.2) 1.1 (0.2) 1.0 (0.2) <0.001
Medical history (%)
 CABG 49.4 63.3 52.0 46.3 36.2 <0.001
 Myocardial infarction 28.1 22.2 29.1 31.3 30.0 0.02
 PTCA 8.7 4.7 5.7 9.0 15.3 0.001
 Valvular replacement 8.9 8.2 8.9 7.6 10.4 0.4
 Other 4.4 1.3 3.8 5 7.4 0.001
Medications (%)
 ACE inhibitor or ARB 53.3 57.3 54.0 50.0 68.9 0.09
 Aspirin 74.6 75.9 72.8 74.3 75.1 0.9
 β-Blocker 59.4 57.9 63.6 60.0 55.8 0.4
 Calcium antagonist 12.9 13.6 12.5 14.0 11.7 0.6
 Diuretic 18.1 26.6 20.4 13.7 10.4 <0.001
 Statin 52.9 50.3 49.2 52.0 60.1 0.01
 Number of medications 3.2 3.5 3.2 3.1 3.1 0.004

Data are presented as mean (SD).

ARB, angiotensin receptor blocker; AWS, average walking speed; BMI, body mass index; CABG, coronary artery bypass graft; HDL, high-density lipoprotein; LV, left ventricular; PTCA, percutaneous transluminal coronary angioplasty, stenting or both.